Health sciences

MedVet Expands Specialty and Emergency Services to Houston, Texas

Wednesday, January 20, 2021 - 10:50pm

MedVet looks forward to providing local general practice veterinarians ongoing support and expanded access to specialty veterinary care.

Key Points: 
  • MedVet looks forward to providing local general practice veterinarians ongoing support and expanded access to specialty veterinary care.
  • "We are very excited to be expanding into the Houston community," said MedVet CEO, Dr. Linda Lehmkuhl .
  • "Area veterinarians and pet owners have long trusted Veterinary Medical Specialists of Houston and Veterinary Surgical Group to provide specialty care for their pets.
  • As part of MedVet, Bay Area Veterinary Specialists will continue to provide Cardiology, Internal Medicine, Medical Oncology, and Surgery services on a referral basis.

Hollister Biosciences Inc. Announces $5 Million Private Placement

Wednesday, January 20, 2021 - 10:36pm

Each Special Warrant shall be automatically exercisable into units of the Company (the Units), as described below.

Key Points: 
  • Each Special Warrant shall be automatically exercisable into units of the Company (the Units), as described below.
  • Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products.
  • Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf.
  • Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the "American Biker".

Inspiring Communities Partners with Wellocity Health to Deliver National DPP Online

Wednesday, January 20, 2021 - 6:00pm

SAN FRANCISCO, Jan. 20, 2021 /PRNewswire-PRWeb/ -- Inspiring Communities, a nonprofit organization based in Richmond, CA with full CDC recognition for delivering in-person National Diabetes Prevention Program (National DPP), has partnered with Wellocity Health to deliver the National DPP online in English and Spanish.

Key Points: 
  • SAN FRANCISCO, Jan. 20, 2021 /PRNewswire-PRWeb/ -- Inspiring Communities, a nonprofit organization based in Richmond, CA with full CDC recognition for delivering in-person National Diabetes Prevention Program (National DPP), has partnered with Wellocity Health to deliver the National DPP online in English and Spanish.
  • The partnership with Wellocity enables Inspiring Communities to increase access, extend its participant base with employers and health plans, and make the best use of a limited supply of lifestyle coaches.
  • "Being a DPP Coordinator requires me to be in contact with my healthy lifestyle coaches and participants", said Minda Chai, DPP Coordinator for Inspiring Communities.
  • Inspiring Communities, a nonprofit organization based in Richmond, CA was founded in 2009 and has achieved full CDC recognition for delivering in-person National Diabetes Prevention Program (National DPP).

Research Marketing And Advertising (RMA) Expands Marketing Services To Clinical Research Industry Nationwide

Wednesday, January 20, 2021 - 4:13pm

RALEIGH, N.C., Jan. 20, 2021 /PRNewswire/ --After more than nine years providing marketing and recruiting services for thousands of clinical research trials, RMA is launching a new website and expanding its services to other clinical research companies nationwide.

Key Points: 
  • RALEIGH, N.C., Jan. 20, 2021 /PRNewswire/ --After more than nine years providing marketing and recruiting services for thousands of clinical research trials, RMA is launching a new website and expanding its services to other clinical research companies nationwide.
  • Since 2011, RMA has provided a variety of clinical research marketing services across a broad range of therapeutic areas.
  • "To that end, we have launched a new website to help provide a quick and easy reference and overview to clinical research organizations in need of assistance with the marketing and advertising side of the clinical research industry."
  • In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services.

Highlands Investments launches Africa's first contract cultivation offering - Canna-Tract™

Wednesday, January 20, 2021 - 3:31pm

Highlands Investments, a licensed cultivator of high-quality, low-cost medical grade cannabis, today launches Canna-Tract

Key Points: 
  • Highlands Investments, a licensed cultivator of high-quality, low-cost medical grade cannabis, today launches Canna-Tract
    CAPE TOWN, South Africa, Jan. 20, 2021 /PRNewswire/ -- "Canna-Tract is Africa's first cannabis contract cultivation offering.
  • We believe that our cost per hectare model will result in one of the lowest cultivation costs per gram today," says Highlands Investments Managing Director, Mark Corbett.
  • With its exceptional growing climate and low production cost, Lesotho is an ideal place to grow commercial volumes of cannabis.
  • After three successful harvests, Highlands is now entering its fourth grow season, harvesting will take place in March/April.

CoVerified Announces Partnership with Mirimus for Nationwide K-12 Pooled Saliva COVID-19 Testing Program

Wednesday, January 20, 2021 - 3:23pm

Working with Mirimus , Inc., a high-throughput pooled saliva testing provider based in Brooklyn, New York.

Key Points: 
  • Working with Mirimus , Inc., a high-throughput pooled saliva testing provider based in Brooklyn, New York.
  • Saliva-based pooled testing occurs when up to 24 individual saliva samples are combined in the testing lab, rather than at a collection site, and processed as a single test.
  • The CoVerifiedPool platform and Mirimus saliva testing are also available for the early education sector, higher education and businesses.
  • This unique skillset led Mirimus to develop SalivaClear, a COVID-19 testing platform that combines saliva-based sampling, pooled testing and PCR diagnostics to improve the scalability, efficiency, cost-effectiveness and accuracy of COVID-19 testing.

2021 Insights into the Global Cystic Fibrosis Clinical Trial Pipeline - ResearchAndMarkets.com

Wednesday, January 20, 2021 - 3:20pm

The "Global Cystic Fibrosis Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Cystic Fibrosis Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.
  • This report provides the most up-to-date information on key pipeline products in the global Cystic Fibrosis market.
  • It covers emerging therapies for Cystic Fibrosis in active clinical development stages including early and late stage clinical trials.
  • The report provides Cystic Fibrosis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Reify Health Announces Global Expansion of StudyTeam to Over 2,700 Clinical Research Sites

Wednesday, January 20, 2021 - 3:00pm

Reify Health , provider of leading cloud-based solutions that connect and empower the clinical trial ecosystem, today announced that StudyTeam is now available to clinical research sites in 100 countries worldwide.

Key Points: 
  • Reify Health , provider of leading cloud-based solutions that connect and empower the clinical trial ecosystem, today announced that StudyTeam is now available to clinical research sites in 100 countries worldwide.
  • Sites using StudyTeam enroll over 15 percent more patients per month compared to sites that dont use StudyTeam.
  • StudyTeam for Sites was developed based on thousands of hours of research with site staff and designed by current and former Research Coordinators at sites.
  • Reify serves the global life science industry, including thousands of clinical research sites, the most innovative biotechs, and the world's largest biopharmaceutical companies.

AVM Biotechnology's Executive Leadership Team Joined by Dr. Manon Cox, MBA, former Protein Sciences Corporation CEO and Dr. Gary Grohmann, former Australian Regulatory Official

Wednesday, January 20, 2021 - 2:42pm

Dr. Deisher will continue in her role as Chairman of the Board and serve as President and Chief Scientific Officer, leading clinical development efforts.

Key Points: 
  • Dr. Deisher will continue in her role as Chairman of the Board and serve as President and Chief Scientific Officer, leading clinical development efforts.
  • The company's first clinical study AVM0703-001 in relapsed/refractory Non-Hodgkin's Lymphoma is actively enrolling patients (ClinicalTrials.gov Identifier: NCT04329728) .
  • Dr. Cox brings a strong history of success, building Protein Sciences Corporation and launching FluBlok, the first recombinant influenza vaccine on the market, leading to its acquisition by Sanofi.
  • AVM Biotechnology provides AVM0703 as well as regulatory templates free of charge for FDA approved Expanded Access or Compassionate Use applications.

Teckro Looks to 2021 and Beyond: Expands Executive Team to Build on Company Mission to Humanize Clinical Trials Through Real-Time Communication

Wednesday, January 20, 2021 - 2:04pm

Now in its 6th year, Teckro is building on its mission to humanize the clinical trials process.

Key Points: 
  • Now in its 6th year, Teckro is building on its mission to humanize the clinical trials process.
  • The ability to engage and access critical study information in real-time eases the burden on all clinical trial stakeholders.
  • A ray of light in this pandemic has been the extraordinary change in clinical trials.
  • The newest product, Teckro Connect, is key to the objective of increasing direct human interactions to improve decision making during clinical trials.